GES-11, a Novel Integron-Associated GES Variant in Acinetobacter baumannii
Open Access
- 1 August 2009
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (8), 3579-3581
- https://doi.org/10.1128/aac.00072-09
Abstract
New extended-spectrum β-lactamase GES-11 was detected in Acinetobacter baumannii BM4674. The enzyme conferred resistance to β-lactams, including aztreonam, and reduced susceptibility to carbapenems. The structural gene was part of a class 1 integron borne by self-transferable plasmid pIP847. GES-type β-lactamases have not been reported previously in A. baumannii .Keywords
This publication has 22 references indexed in Scilit:
- Résistance aux quinolones de type qnr chez les entérobactéries productrices de bêta-lactamases à spectre élargi à Abidjan en Côte d’IvoirePathologie Biologie, 2008
- Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment OptionsClinical Infectious Diseases, 2008
- Contribution of extended-spectrum AmpC (ESAC) β-lactamases to carbapenem resistance in Escherichia coliFEMS Microbiology Letters, 2008
- Carbapenemases: the Versatile β-LactamasesClinical Microbiology Reviews, 2007
- Modes and Modulations of Antibiotic Resistance Gene ExpressionClinical Microbiology Reviews, 2007
- Genetic Environment of Quinolone Resistance Gene qnrB2 in a Complex sul1 -Type Integron in the Newly Described Salmonella enterica Serovar KeurmassarAntimicrobial Agents and Chemotherapy, 2006
- Comparative Genomics of Multidrug Resistance in Acinetobacter baumanniiPLoS Genetics, 2006
- Molecular Characterization of a Cephamycin-Hydrolyzing and Inhibitor-Resistant Class A β-Lactamase, GES-4, Possessing a Single G170S Substitution in the Ω-LoopAntimicrobial Agents and Chemotherapy, 2004
- Novel GES/IBC extended-spectrum β-lactamase variants with carbapenemase activity in clinical enterobacteriaFEMS Microbiology Letters, 2004
- Novel GES/IBC extended-spectrum ?-lactamase variants with carbapenemase activity in clinical enterobacteriaFEMS Microbiology Letters, 2004